Mirjana Novković

Istraživač saradnik
Laboratorija za molekularnu biologiju (LMB)

Institut za molekularnu genetiku i genetičko inženjerstvo (IMGGI),
Univerzitet u Beogradu,

V. Stepe 444a, 11010 Beograd, Srbija
Mob: +381 65 397 66 58
Tel:   +381 11 397 66 58
Fax:  +381 11 397 58 08
E-mail: mirjananovkovic@imgge.bg.ac.rs                                   

OBRAZOVANJE

2012 - Doktorand, Laboratorija za molekularnu biologiju, IMGGI, UB
2012 - Diplomirani biolog, BF, UB

ISTRAŽIVAČKO ISKUSTVO

2012 - Doktorant, LMB,IMGGI, UB
2011 - 2012 - Istraživač volonter u Centru za humanu molekularnu genetiku pri Biološkom fakultetu

OBLAST NAUČNOG INTERESOVANJA

  • Biomarkeri humanih bolesti.
  • Molekularna genetika.
  • Analiza DNK i molekularna dijagnostika.
  • Farmakogenetika u kardiovaskularnim bolestima.
  • Regulacija i ekspresija gena CYP2C9 i CYP2C19.
  • Epigenetički mehanizmi regulacije gena. 

ODABRANI NAUČNI RADOVI

  • Novkovic M, Matic D, Kusic-Tisma J, Antonijevic N, Radojkovic D, Rakicevic L (2018) Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel. Eur J Clin Pharmacol 74 (4): 443-451 DOI 10.1007/s00228-017-2401-5
  • Mitropoulou C, Fragoulakis V, Rakicevic LB, Novkovic MM, Vozikis A, Matic DM, Antonijevic NM, Radojkovic DP, van Schaik RH, Patrinos GP (2016) Economic analysis of pharmacogenomic-guided clopidogrel treatment in Serbian patients with myocardial infarction undergoing primary percutaneous coronary intervention. Pharmacogenomics  DOI 10.2217/pgs-2016-0052
  • Backovic D, Ignjatovic S, Rakicevic L, Novkovic M, Kusic-Tisma J, Radojkovic D, Strugarevic E, Calija B, Radak D, Kovac M (2016) Clopidogrel High On-Treatment Platelet Reactivity in Patients with Carotid Artery Stenosis Undergoing Endarterectomy. A Pilot Study. Curr Vasc Pharmacol 14 (6): 563-569

Please publish modules in offcanvas position.